Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neumora Therapeutics, Inc. - Common Stock
(NQ:
NMRA
)
11.71
+0.03 (+0.26%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Neumora Therapeutics, Inc. - Common Stock
< Previous
1
2
Next >
7 Stocks with Strong Insider Buying: December 2023
December 17, 2023
Here are just a few of the top stocks with strong insider buying that all investors may want to watch heading into 2024.
Via
InvestorPlace
Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
December 12, 2023
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
November 30, 2023
Shares of Salesforce, Inc.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
November 30, 2023
It's time for a breakdown of the biggest pre-market stock movers as we check out all of the hottest news on Thursday morning!
Via
InvestorPlace
Analyst Expectations for Neumora Therapeutics's Future
November 08, 2023
Via
Benzinga
Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 04, 2023
Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20...
Via
Benzinga
Neumora Therapeutics Announces NMRA-266 IND Clearance and Initiation of Phase 1 Clinical Study
November 27, 2023
NMRA-266 is a highly selective positive allosteric modulator of the M4 muscarinic receptor, a clinically validated target for the treatment of schizophrenia
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
November 01, 2023
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics to Participate in Upcoming Conferences in November
October 30, 2023
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On Tuesday
October 10, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Tuesday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023
October 10, 2023
Via
Benzinga
Why Neumora Therapeutics Analysts Are Bullish About Major Depressive Disorder Drug
October 10, 2023
Shares of Neumora Therapeutics Inc (NASDAQ: NMRA) were trading lower on Tuesday, a month after the company announced its IPO on the NASDAQ exchange.
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Neumora Therapeutics Announces Appointment of Robert Lenz, M.D., Ph.D., as Executive Vice President, Head of Research and Development
October 10, 2023
Dr. Lenz brings 20 years of neuroscience drug development expertise, with deep experience implementing successful clinical programs to support the development of novel medicines
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Specialty Asian Grocer Maison Solutions Opens For Trading
October 08, 2023
Following a couple of high-profile trading debuts, the IPO market slowed down again. There was only one public offering of note this week, with California-based specialty Asian grocer Maison Solutions...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Why Intelligent Bio Solutions Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
October 02, 2023
Gainers AERWINS Technologies Inc. (NASDAQ: AWIN) shares climbed 86.1% to $0.2248 after the company said it is considering strategic alternatives for its non-core operations.
Via
Benzinga
Ticking Time Bombs: 3 New Stocks to Dump Before the Damage Is Done (IPO)
September 28, 2023
The IPO market is still far from being as hot as it was in 2021, and these three recently listed stocks are solid proof of that.
Via
InvestorPlace
Topics
Initial Public Offering
Exposures
Securities Market
Jabil, Chico's FAS And Other Big Stocks Moving Higher On Thursday
September 28, 2023
U.S. stocks traded mixed, with the Dow Jones gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Shares of Neumora Therapeutics Slumped This Week
September 21, 2023
The clinical-stage biotech just had its IPO last week.
Via
The Motley Fool
Topics
Initial Public Offering
Exposures
Securities Market
Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
September 20, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.
Via
Benzinga
SoftBank-Owned Arm Jumps 20% In Market Debut
September 17, 2023
British chip designer Arm made its public debut on Thursday, with the shares jumping 10% right as the stock opened for trading. Arm's was the most high-profile Nasdaq IPO in the last few years, with...
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.